title: Interstitial thermoradiotherapy: thermal dosimetry and clinical results.
abstract: From August 1977 to August 1986, 72 patients with advanced primary or recurrent cancers were treated using interstitial thermoradiotherapy. Sites treated included the pelvis in 49 patients, the head and neck in 15, and other sites in six. Median tumor volume was 52 cm3, and all but nine patients had received prior irradiation. In 69 patients, hollow stainless steel catheters were implanted and used as electrodes with a 0.5 MHz radiofrequency (RF) generator, whereas in three patients, standard plastic Henschke tubes were used with a commercially available interstitial microwave (MW) system operating at 915 MHz. Most patients were heated intraoperatively for 30 minutes, aiming for a minimum measured intratumoral temperature (Tmin) of 42 degrees C. The implant was occasionally preceded by external irradiation, and after hyperthermia, the catheters were afterloaded with 192Ir for brachytherapy. Tmin exceeded 42 degrees, 42.5 degrees, 43 degrees, and 44 degrees in 25, 16, 12, and 3, respectively, of 70 patients with temperature data available, and the probability of successful heating was independent of tumor volume or site. Twenty-five of 69 (36%) evaluable patients achieved a complete response (CR). Probability of CR demonstrated a significant univariate dependence upon Tmin, radiation dose, site treated, and tumor volume, but multivariate analysis showed only three significant predictor variables: tumor volume, radiation dose, and Tmin. The probability of a CR ranged from 95% for patients with small tumors receiving high doses of radiation and adequate heat, to 5% for patients with large tumors receiving low radiation doses and less than adequate heat. Of 25 patients with CR, 10 relapsed; median response duration was less than 18 months, depended marginally upon disease site, and was independent of Tmin, radiation dose, and tumor volume. Seventeen patients sustained a complication, of which nine were severe enough to require hospitalization or surgery. All severe complications occurred in patients with pelvic tumors. The probability of a complication of any severity had a significant univariate association with maximum intratumoral temperature (Tmax) and tumor size. We conclude that interstitial thermoradiotherapy offers the promise of heating large tumors in locations where externally applied hyperthermia has not been successful.
authors.affiliation: Department of Radiation Oncology, University of Arizona Cancer Center, Tucson 85724.
authors.forename: D S
authors.initials: DS
authors.lastname: Shimm
authors.forename: J M
authors.initials: JM
authors.lastname: Kittelson
authors.forename: J R
authors.initials: JR
authors.lastname: Oleson
authors.forename: S A
authors.initials: SA
authors.lastname: Aristizabal
authors.forename: L C
authors.initials: LC
authors.lastname: Barlow
authors.forename: T C
authors.initials: TC
authors.lastname: Cetas
mesh_terms: D001918:Brachytherapy / Q000295:instrumentation / Q000379:methods; D003131:Combined Modality Therapy; D003972:Diathermy / Q000295:instrumentation / Q000379:methods; D006801:Humans; D007496:Iridium Radioisotopes / Q000627:therapeutic use; D009369:Neoplasms / Q000628:therapy*; D011379:Prognosis
chemical_list: D007496:Iridium Radioisotopes